James Xue

Biography

 Dr. Xue is a biopharmaceutical executive with extensive experience in corporate strategy and operations, global business and market development and entrepreneurship.  As the company’s founder, he set the vision of accelerating the development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia.  He was founder and President of CANbridge Consulting LLC which served health care clients in North America and Greater China region and was a Venture Partner at Tullis Health Investors.  Dr. Xue was a senior executive at Genzyme where he spent 10 years in various managerial positions with increasing responsibilities in business development, portfolio strategy, commercial and general management.  During his tenure as the founding General Manager of Genzyme China, Dr Xue developed and implemented Genzyme’s multi-prom business strategy and plan, built a fully-fledged organization and successful business foundation and pioneered orphan drug commercial and societal initiatives including launching the first enzyme replacement therapy and the first orphan drug aid program in the country.  Dr. Xue started his career in biotech industry as a research scientist at Kosan Biosciences in the San Francisco Bay Area.  He holds a B.S. in Pharmaceutical Chemistry from Peking University School of Pharmacy, a Ph.D. in Bioorganic Chemistry from Brown University and a M.B.A. from Darden School of Business, University of Virginia. He received postdoctoral training at University of California San Francisco and executive training from INSEAD and Wharton Business School.

Research Interest

 Pharma